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Compared to elsewhere in the United Kingdom, drug policy in Northern Ireland has for the most 
part failed to incorporate harm reduction strategies. In light of the conservative drug policies, the 
purpose of this study was to investigate the nature and extent of risk behaviors among injecting 
drug users (IDUs) in Northern Ireland. Data for this study were drawn from in-depth interviews 
with 39 IDUs in Northern Ireland. The findings suggest that most IDUs engage in extensive risk 
behaviors that pose risk for HIV, Hepatitis B and C, and other infectious disease. Moreover, these 
risk behaviors are linked to the scarcity of new needles and a general lack of knowledge about 
injection practices that reduce risk for infectious disease. These findings are discussed in the 
context of conservative drug policies. 
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INTRODUCTION 
Most research in Northern Ireland has concentrated on issues relating to the Irish political conflict. 
For example, scholars have focused on the historical aspects of the conflict (1,2), paramilitary 
groups (3,4), the law and legal system (5), media portrayals of the conflict (6), victims of the 
conflict (7), state violence (8,9), and the latest peace process (10). One disadvantage of this focus 
is that few studies have examined aspects of health and social behavior in the region. Research 
into drug misuse is by no means an exception; compared to other industrialized cultures, drug 
misuse studies in Northern Ireland emerged late—in the 1990s—and have concentrated largely 
on drug use prevalence among youth. In Northern Ireland, several health professionals as well as 
government officials have long maintained that heroin use has presented few problems in the 
region (11). These conclusions have been based on self-report studies and public health 
indicators of heroin use and injecting in the region. For instance, self-report studies of adults and 
youth in Northern Ireland have generally shown that the prevalence of heroin use is low, i.e., 
approximately 1% or less (12,13). However, survey methods are likely to exclude or 
underrepresent heroin users; when heroin users are included in the sample, researchers have 
suggested that they are likely to display high rates of refusal or to underreport drug use (14,15). 
 
Public health indicators of heroin use and injection in Northern Ireland also have suggested low 
levels of use. For example, local physicians are required to notify the Chief Medical Officer in 
Northern Ireland if they attend a patient who is ‘‘addicted’’ to one or more specified drugs (i.e., 
several opiates, cocaine). Notification can be based on suspected addiction, if that diagnosis is 
based on ‘‘reasonable’’ grounds. Notification data from Northern Ireland showed slight increases 
through year-end 1996, however, in 1997, the number of notified ‘‘addicts’’ reached 162 (16), a 
substantially higher figure than in previous years. In 1998, the number of notified ‘‘addicts’’ 
increased to 229, the highest number ever recorded from this data source. Further, 70% of the 
persons notified in 1998 were suspected or known to have ‘‘misused’’ heroin. These data are 
limited in that they depend greatly on physician subjectivity with regards to the concept of 
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‘‘addiction.’’ Notification data can also be affected by the degree of compliance among physicians 
as well as an increase in the number of persons seeking treatment (17). 
 
Reports of HIV infections with injecting drug use as the likely mode of transmission indicate very 
low numbers in Northern Ireland. Cumulative data through June 2000 reveal seven cases of HIV 
infection for this category (18), with the first case having been reported in 1987 (19) [the 1997 
total population of Northern Ireland was estimated to be approximately 1,675,000 persons (20)]. 
Moreover, fewer than 20 new cases of Hepatitis C infection with a reported risk factor of injecting 
drug use were reported in 1998 (21). These data suggest that infection rates are low, however, 
the data are based on voluntary testing and little is known about the extent of routine testing 
among injecting drug users (IDUs) in Northern Ireland. Further, studies that investigate the 
prevalence of HIV and Hepatitis C among injectors in Northern Ireland are lacking. 
In some ways, the government perspective on heroin use coincides with the findings from much of 
the available data. However, if the notification data are in any way an accurate reflection of an 
increase in users, the official view has failed to consider this increase. Equally important, research 
that investigates heroin or injecting drug use in Northern Ireland is lacking, therefore data that 
might dispute these official claims have not been available. Some researchers have viewed the 
public health indicators of illicit drug use in Northern Ireland with skepticism, largely because data 
collection is hindered by extensive social stigma surrounding drug use, and, in particular, heroin 
and injection (22). Specifically, heroin users often are fearful that police, paramilitaries, and anti-
drug vigilantes1 will discover their drug use, and for some, these fears can affect their willingness 
to seek drug treatment, or be tested for HIV and other infectious diseases associated with drug 
injection (24). 
 
One consequence of the official claims about low levels of heroin use is that drug policies in 
Northern Ireland relating to heroin and injection differ substantially from elsewhere in the United 
Kingdom, as well as in the Republic of Ireland. For example, needle exchange schemes were not 
implemented until 2001. Treatment services for heroin users are quite limited in Northern Ireland; 
methadone maintenance programs have not been implemented and methadone prescribing is 
strongly discouraged (at times the prescribing physician receives a written reprimand from the 
Chief Medical Officer). Therapeutic communities are not available and self-help groups, such as 
Narcotics Anonymous, for the most part are found in the Belfast area only. Additionally, organized 
street outreach services that assist drug users or injectors have yet to be implemented in Northern 
Ireland. The present study investigates risk behaviors, namely injection behaviors and practices, 
among heroin users in Northern Ireland. The methods by which IDUs manage drug lifestyles in 
the context of considerable social stigma and conservative drug policies are the primary focus of 
this paper. The study represents one of the first research investigations into heroin use and 
associated risk behaviors in the region. 
 
METHODS 
The overall study was based on in-depth interviews with 43 current or former users of heroin who 
had used heroin (injected or ‘‘chased the dragon’’2) in Northern Ireland. Given the exploratory 
nature of the study and the limited research into heroin use in the region, ‘‘any use of heroin in 
Northern Ireland’’ was the only criterion for study participation. The study commenced in 
September 1997, although the majority of interviews were conducted in 1998 and 1999. 
Respondents were recruited largely through ‘‘gatekeepers’’ and ‘‘snowball sampling’’ (27) 
whereby persons who completed an interview were asked to refer other persons (e.g., friends, 
acquaintances, partners) who had used heroin. These sampling strategies are instrumental for 
                                               
1 Anti-drug vigilantes in Northern Ireland are individuals who are vehemently opposed to illicit drug use. 
Their actions have included violent assaults directed largely against alleged drug dealers. One group, 
calling itself, Direct Action Against Drugs (DAAD), has claimed responsibility for the deaths of several 
suspected drug dealers in Northern Ireland 
2 2 ‘‘Chasing the dragon’’ represents one route of administering heroin. Although techniques can vary, 
generally the drug is placed on tin foil and heated from beneath the foil. The vapors are then inhaled by the 
user (25,26). 
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reaching hidden populations such as illicit drug users (28). Once a potential respondent made 
contact with the interviewer, the interviewer then described the purposes of the study (e.g., that 
the research focused on health and various lifestyle issues pertaining to heroin use). The 
interviewer also stated that she had been involved in studies of heroin use in the United States, 
and that research into heroin use in Northern Ireland was quite limited; the study hoped to fill that 
gap. The interviewer was employed as a university teacher and researcher in the Department of 
Sociology, Queen’s University, Belfast. She was 38 years old when the study commenced, and 
her accent immediately identified her as a foreigner, an ‘‘outsider’’ with regards to the wider Irish 
political conflict.3 All individuals who made contact with the researcher and requested an interview 
subsequently completed an interview. However, a few respondents appeared for an interview 
weeks after the initial contact had been made. The number of heroin users who became aware of 
the study, but who never requested an interview is not known. 
 
The interview guide consisted of a number of items relating to patterns of heroin use (e.g., 
frequency, dosage, age at onset, method of administration, patterns of use), risk behaviors 
associated with injection practices, descriptions of first, last and heaviest use of heroin, treatment 
experiences (including ‘‘self-help’’ strategies), interactions with medical staff regarding heroin use, 
and related lifestyle and attitudinal issues. Historical information on other drug use as well as 
demographic data were collected at the conclusion of the interview. Interviews were conducted 
within a one- to two-hour time frame and in various settings (e.g., university offices, respondents’ 
homes). The interview required very basic communication skills of respondents who participated 
in the study. Although the interview guide was not formally pre-tested with a sample of heroin 
users, various questions were phrased differently in subsequent interviews based on responses 
from previous interviews.4 Given the reflexive nature of qualitative interviews, questions were 
added to subsequent interviews when important issues emerged in previous interviews. 
 
Respondents were assured of anonymity and confidentiality, and paid P15–20 (US$ 21.60–28.80) 
for their participation in the study. Several ethical protocols were followed in the study, in addition 
to the assurances of anonymity and confidentiality. First, the interview setting was determined by 
respondents’ preferences, which provided some shift of the power relationship between 
interviewer and respondent. Second, respondents were reminded at various points during the 
interview, that they could end the interview at any time without consequence, and still be paid for 
limited participation (one respondent terminated the interview early, because of sickness 
associated with withdrawal). Third, although the study was anonymous and therefore final 
interview transcriptions could not be sent to study participants for comment, a draft final report 
was prepared (complete with quotations from anonymous respondents) and distributed to one 
gatekeeper for review. This gatekeeper, who maintained several informal contacts with current 
and former users, was asked specifically to identify any comments or text that might harm or 
identify a particular respondent, or that might harm heroin users generally. 
 
The primary researcher conducted and transcribed all of the interviews. Clearly, studies which use 
interviewers from academia promote a differential balance of power between respondent and 
interviewer. The researcher utilized a number of strategies to reduce this power imbalance, such 
as introducing herself and asking respondents to refer to her by her first name, facing 
respondents directly without physical barriers such as desks, and offering to interview 
respondents in their homes. Additionally, for some respondents, the university affiliation provided 
credibility to the study and suggested that respondents’ experiences were important. 
                                               
3 3The extent to which the interviewer’s outsider status affected study participation is not known. However, 
some users appeared to be pleasantly surprised that an outsider showed interest in their lifestyles. 
 
4 For example, the preliminary interviews included several terms (e.g., ‘‘booting’’) based on nomenclature 
associated with certain heroin user subcultures in the United States. Some of this nomenclature was 
unrecognizable among participants in the Northern Ireland study. The researcher learned the culturally-
specific nomenclature as the study continued. 
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Characteristics of the Sample 
Most study participants were male (N¼36) and respondents’ ages ranged from 18 to 48 
(mean¼30 years; median¼29). A number of respondents were uncomfortable with the question of 
religious background (i.e., Catholic or Protestant) or, equally important, ethnic identity (i.e., Irish or 
British). Therefore, these items were excluded from the demographic history component. The 
omission of these data precluded any external interest (e.g., from media) in determining whether 
heroin use was disproportionately associated with a particular religious or ethnic group, a finding 
that might have contributed to stereotypical assumptions about that group. The researcher did 
observe, however, that the majority of respondents in the study had used heroin in the company 
of injectors whose religious background differed from their own. Indeed, one Irish injector noted 
that he would have injected with a member of the British monarchy (023). 
 
Approximately 50% of the sample (N¼22) had children, however, only nine respondents reported 
that their children lived with them at the time of the interview. Twenty-six percent (N¼11) of the 
respondents were employed in part- or full-time work at the time of the interview, 7% were 
students, and 61% of the sample were unemployed (information was missing for three 
respondents). The preliminary interviews included a question about sources of income, however, 
several respondents were uncomfortable with this question, thus, the item was omitted in 
subsequent interviews. Although some of the respondents were born and raised in areas outside 
Belfast, most resided in Belfast at the time of the interview, thus, the sample is based largely on 
persons who resided in an urban setting during some or most of the heroin career. Their 
experiences may differ substantially from heroin users who live elsewhere in Northern Ireland. For 
example, a study conducted in Australia found that rural and urban injecting drug users differed in 
terms of their injecting practices, needle sharing, and prevalence and incidence of Hepatitis C 
(29). A second study found fewer differences between rural and urban injectors in Scotland (U.K.), 
although urban IDUs had higher rates of HIV and were more likely to share injection equipment 
with persons outside their immediate social network (30). 
 
The average age at which respondents initiated heroin use was 20 years and the majority (N¼26) 
had initiated heroin use in other countries. Thirty per cent of respondents (N¼13) had initiated 
heroin use through injection. About one-half (N¼21) initiated through chasing; 12% (N¼5) 
initiated through snorting/sniffing, and 7% through smoking (non-chasing). Data on route of 
administration at initiation was missing for one respondent. Of the 29 respondents who had 
initiated heroin use through non-injection, 25 had progressed to injection. The other four 
participants had chased but had never injected heroin, and thus are omitted from the present 
analysis (final N¼39). 
 
Heroin was the preferred drug of choice for most respondents, however, the vast majority of study 
participants had either never been exposed to or had never completed treatment for heroin use. 
The average length of time between the year of initiation into heroin use and the year of interview 
was 10.7 years (range 1 to29 years). Of the 39 injectors, 24 had been using heroin for ten or more 
years. However, usage since initiation varied considerably. For example, one respondent had 
used heroin and crack cocaine for five years, followed by a five-year period of abstinence. He 
reported ‘‘dabbling’’ (i.e., using infrequently and/or small amounts) with heroin in the year prior to 
the interview (011). Another reported that ten years prior to the interview he had been using 3.5 
grams of heroin per day over a period of several months (‘‘No one believed [that] I was using that 
much but I was’’— 041). That pattern of usage was followed by a 16-month period during which 
he used small amounts, and on a few occasions only. Another reported using 0.5 to 1 gram of 
heroin per day for 14 to 15 years. His last injection occurred three months prior to the interview, 
and he purposely abstained from injection since that time. However, he had chased the drug on 
several occasions during that time, preferring that method of ingestion because, ‘‘I’m trying to get 
off it’’ (014). 
 
Please use the following citation: McElrath K (2001) Risk behaviors among injecting drug users in Northern Ireland (Author postprint) in 
Substance Use & Misuse 36(14), 2137-57, [Accessed: (date) from www.drugsandalcohol.ie]      5 
 
 
Only four persons reported current use of alcohol; one respondent indicated that alcohol was his 
drug of choice. Eighty-three percent of the sample smoked approximately 20 cigarettes daily. 
Ninety-eight percent of the respondents had consumed cannabis at some stage, and 35% of the 
sample (N¼15) had used cannabis daily during the six-month period prior to the interview. Ninety-
three percent of the respondents had used hallucinogens (LSD or magic mushrooms), and 95% 
had consumed Ecstasy (MDMA). Approximately half the sample (N¼21) had initiated Ecstasy use 
after heroin initiation, a finding that might reflect drug preferences, differences in drug markets, or 
the historical availability of Ecstasy in Northern Ireland (anecdotal evidence suggests that MDMA 
markets emerged largely in the 1990s). 
 
Nearly all of the respondents (98%) had used amphetamine, and approximately one-third had 
injected the drug. Ninety percent of the sample had snorted powder cocaine, with 63% reporting 
having had injected the substance. The majority of respondents (80%) had used crack cocaine 
and several persons had injected crack cocaine, a behaviour that reportedly has been increasing 
in London (31). With the exception of heroin, other opiates, and cannabis, however, most 
respondents had not used these other drugs ‘‘regularly.’’ For example, 12 persons had used 
cocaine (through snorting or injecting) during the six-month period prior to the interview, however, 
only three persons had used cocaine once a month or more during that time period. Similarly, only 
5% had used amphetamine once a week or more in the six months prior to the interview. 
 
Several respondents reported using other opiates, particularly when heroin was not available. 
Following heroin, Dihydrocodeine and Morphine Sulfate Tablets (MSTs) were the most common 
opiates used among respondents. Additionally, the majority of respondents had used 
Temazepam, largely to ease withdrawal symptoms associated with heroin use. Seventy-seven 
percent of respondents had injected Temazepam, however, manufacturers have now changed the 
drug’s form, making it more difficult to inject. 
 
Trust and Validation 
Qualitative and ethnographic studies into illicit drug use in Northern Ireland were, for the most 
part, non-existent when the present study commenced. As a consequence, trusting relationships 
between drug researchers and drug users had never been developed. Obtaining access to the 
study population clearly presented difficulties. Additionally, the long history of political conflict has 
created a level of suspicion about researchers who seek information. In some Irish nationalist 
neighborhoods, for example, residents maintain the perception that several years ago, members 
of the British Army posed as survey researchers in order to gather intelligence about people’s 
lifestyles, and their houses. More recently, an Irish nationalist political party advised people that 
they should not participate in a particular survey for fear that the information might be used 
against them. Further, the largest republican paramilitary group, the Irish Republican Army (IRA), 
has maintained an anti-drug ideology for several years and members of that group have been 
involved in informal ‘‘policing’’ within various neighborhoods. 
 
The nature of the political conflict also affects Protestant drug users, particularly when they reside 
in neighborhoods characterized by a heavy loyalist paramilitary5 presence. For example, one 
Protestant respondent had been prescribed dihydrocodeine by his physician but purposely 
avoided his local pharmacy for fear that his identity as a ‘‘drug user’’ would be disclosed to local 
paramilitaries. Another Protestant male voiced considerable fears about loyalist paramilitaries, 
and only came forth for an interview after repeated telephone conversations with and 
reassurances by the researcher. These concerns are firmly embedded in local folklore within 
several heroin user sub-cultures. 
 
                                               
5  Loyalists are persons—largely Protestant—who believe that Northern Ireland should remain within the 
United Kingdom, hence they are ‘‘loyal’’ to the British Crown. Further, loyalists tend to believe that violence 
is justified in the pursuit of maintaining the tie with Britain 
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To begin the process of establishing trust, the researcher first made contact with a former heroin 
user who had been ‘‘clean’’ for four years. He had disclosed his past drug use to several people 
(i.e., non-users) in the community and was quite willing to meet with the researcher. He provided 
several suggestions for recruitment and later served as an important gatekeeper. To facilitate trust 
with respondents, the researcher often showed them articles on drug use that she had authored. 
At other times, the researcher provided her home telephone number as a point of contact. 
 
This decision was a conscious one, the assumption being that potential respondents might be 
more willing to trust the research if the researcher could demonstrate that she trusted potential 
respondents. To illustrate further, the researcher was on an 18-week maternity leave midway 
through the study. Fieldwork with hidden populations, however, cannot realistically cease for 18 
weeks and then recommence. The decision was made to continue with interviewing during the 
period of maternity leave, and with study participants’ approval, the researcher’s young infant 
accompanied her to the interview site (including participants’ homes). The initial intent was for 
practical reasons only, however, in time the researcher observed that interviews which occurred in 
these settings yielded extremely productive data and discussion. Most of the other strategies were 
used in order to promote trust and to generate comfortable interview settings for the respondents. 
Despite these attempts, however, ‘‘. . . we can never be certain of how members of such 





The majority of study participants reported great difficulties in obtaining new needles/syringes to 
be used for injecting heroin and other drugs. Needles/syringes are most often sold from 
pharmacies in packages of 10 at a cost of two pounds sterling (US$2.88). Pharmacists, however, 
use their discretion in the decision to sell. Nearly all of the respondents reported at least one 
instance whereby a pharmacist refused to sell them needles/syringes. Several respondents 
reported that these refusals occurred on a regular basis (discussed below). The limited supply of 
needles as well as the cost of purchasing needles, contributed to a number of behaviors that pose 
risk for HIV, Hepatitis C and other infectious diseases, and contribute to ill-health in general. 
 
Obtaining Needles/Syringes 
A number of difficulties were reported by respondents who tried to purchase needles from 
chemists, particularly in areas outside Belfast (e.g., 029, 030). 
 
‘‘One chemist sold out of decency. Another chemist stopped selling when the deaths 
occurred . . . [A third chemist required you] to sign your name’’ [for needles but not for 
prescription or over-the counter drugs] (004, male). 
 
This participant reported that IDUs within his injecting group did not often buy needles from 
chemists because ‘‘too many people, going back too often would spoil it for us.’’ (004). A 
participant who lived in a small town reported that he never purchased needles from a chemist 
there because, ‘‘They all know my family’’ (034). 
 
One study participant reported that he purchased needles from dealers in the town of Ballymena 
because chemists in the area will not sell them to him (030). A few Belfast respondents reported 
that Belfast users have ‘‘swapped needles for gear [heroin] in Ballymena’’6 (001). Indeed, when 
this researcher asked a few users how she could recruit other respondents from Ballymena, one 
                                               
6 Ballymena is located approximately 30 miles north of Belfast. Compared to IDUs in cities located outside 
Northern Ireland, these transactions are unusual in that urban users often travel to a smaller town in order 
to buy heroin. 
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suggested that she offer new needles/syringes as opposed to money as an incentive for study 
participation. 
 
Most of the Belfast users reported that chemists refused to sell needles/syringes to them at 
various times. For some persons, refusals occurred frequently. Some perceived that a successful 
purchase depended on the ‘‘way you looked ’’ (006), or never visiting the same chemist twice 
(048). The interview data clearly suggested that most respondents had made several attempts to 
purchase new needles but faced with structural barriers, were forced to use various negotiation 
skills in order to obtain the injecting equipment. For example, several respondents attempted to 
‘‘disguise’’ their drug injector identity by portraying themselves as diabetics. Others recalled that 
they had informed a chemist that a diabetic relative needed to inject insulin but that the relative 
needed a new supply of needles. In these situations, many respondents requested a particular 
size (e.g., 1 ml) and dimension (e.g., micro fine) of needle: ‘‘You have to know what you’re asking 
for’’ (027). Some reported that a few chemists were willing to sell them 2ml needles but that this 
size of needle was unacceptable for injecting, in part because of the problems that it posed for 
veins (051). A few respondents eventually avoided pharmacists altogether: 
 
‘‘I’ve got no money for works. [I’ve] tried to buy here but most chemists wouldn’t sell 
them and I didn’t know the diabetic lingo’’ (053). 
 
Others collected needles/syringes from exchange schemes that operate in other countries during 




Needles are intended to be used one time only. However, the lack of available needles 
contributed greatly to multiple injections with the same needle. One respondent noted that he 
often used the same needle several times per day over a period of a few weeks (041). Another 
reported: ‘‘I’ve used one needle 14 times over a few days’’ (053, male, age 29). 
 
Some estimated that they used one needle to inject as many as 30 times (045, 080) and one 
reported that his ‘‘jugular’s messed as well’’ (045). Others were less precise, noting that ‘‘we’d use 
’til they got blunt’’ (004) and using blunt works was described as ‘‘reversing a double decker into 
your arm’’ (071).  
 
Cleaning Injection Equipment 
Bleach is an extremely effective way to clean drug injection equipment and when used properly 
can inactivate the HIV found on such equipment (33). To their credit, some study participants 
reported that they used bleach to disinfect needles (008) and other injection equipment. One 
respondent made specific reference to bleach, and the sterilizing of spoons and other injection 
equipment (009). He also reported that when injecting within a group of IDUs he ‘‘would make 
sure it [the needle and syringe] would be clean for everyone.’’ 
 
A few study participants had never heard that bleach should be used to clean equipment (e.g., 
003). Some used other, less effective means to clean needles, e.g., cold water (027), vodka 
(003). Younger IDUs with shorter injection careers have been found to engage in more risk 
behaviors than older IDUs (35). A male respondent in the present study noted that ‘‘long term 
users would use bleach’’ but as for less experienced injectors, he recalled that: 
 
‘‘Nobody had a clue. We got no information—only from other junkies. We just 
mimicked what we saw [other users do]’’ (004, initiated heroin use at age 25). 
 
Data collected from study participants, however, indicated that experienced injectors also 
engaged in considerable risk behaviors for infectious disease. For example, a respondent who 
initiated heroin use in 1981 reported that he used a sterilizer todisi nfect needles, but only when 
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he prepared toinjec t at home (041). Another admitted that it was ‘‘difficult’’ to use bleach when he 
injected in the middle of the night (043, initiated heroin use nine years before the interview). 
 
‘‘Sharing’’ Needles and Other Injection Equipment 
The term ‘‘needle sharing’’ has been described as a misnomer in that it suggests that the behavior 
represents ‘‘an act of reciprocity’’ based on the altruistic beliefs of the loaner (35). In fact, the 
lending and borrowing of needles is influenced greatly by their lack of availability (36). Nearly all of 
the injectors in the present study had at some point used another injector’s needle/syringe. Some 
noted that they were less likely to borrow injection equipment in places where new 
needles/syringes were available, e.g., Dublin (Republic of Ireland), Glasgow (U.K.), and London 
(U.K.). The scarcity of new needles/syringes in Northern Ireland contributed greatly to the loaning 
and borrowing of this equipment: 
 
‘‘People use another’s syringe if there’s no option. I don’t think they [health officials, 
government] understand that. It’s the height of stupidity, to make it difficult to get 
syringes. . .We’ve no choice. . .people are driven by their desire to obtain’’ (051, has 
tested positive for Hepatitis C) 
 
 ‘‘I’d share [needles] with Hep C people’’ (045, age 32). 
 
For some, the urgency to use heroin took precedence over a search for a new needle: ‘‘When 
you’re sick enough, you’d use somebody else’s’’ (041, male, age 32). 
 
Consistent with research findings reported elsewhere (36), the data drawn from the present study 
indicate that some study participants defined ‘‘sharing’’ in terms of their relationship with the 
loaner/borrower. That is, sex partners did not necessarily view the use of the partner’s needle as 
a behavior that constitutes ‘‘sharing’’ (001, 002, 003). A female respondent reported that she 
never ‘‘shared’’ needles, but later in the interview she noted that she and her boyfriend used the 
same needle/syringe on every occasion that they injected together (021). Another female reported 
that she and her boyfriend always shared needles and for the most part she appeared to be 
unconcerned about loaning their equipment: ‘‘It’s up to anyone else if they wanted to use our 
needle’’ (035). A male respondent reported that he and his girlfriend always ‘‘shared’’ needles: 
‘‘[We were having] unprotected sex, so why not?’’ (071, age 26). 
 
Others noted the distinct possibility of ‘‘accidental’’ use of another’s needle/syringe, despite 
attempts not to do so:  
 
‘‘I may have accidentally shared. I’d wake up—we’d both wake up and there’d be two 
[sets of works] on the table. [We couldn’t recall] which one was whose.’’ (074, male, 
age 43). 
 
‘‘At first, there ’s no way that we’d share [with one another]. He set his here . . . and 
then after a while we wouldn’t know whose needle was whose.’’ (005, female) 
 
‘‘[At times] I can’t remember which is my own’’ (073, female).  
 
A few study participants acknowledged the importance of sterile needles but appeared 
lackadaisical about ‘‘borrowing’’ from others, even when they believed that the loaner was positive 
for HIV-antibodies. A female respondent reported that she did not often use bleach but did so 
during the last injection episode while in the company of two other IDUs. Prior to that event she 
had heard that one of the IDUs was HIV antibody positive. She made no attempt to clean the 
needle during the injection episode, although one of the IDUs who was present did so for her 
(073). 
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Another respondent described a situation in which he was in the company of two other injectors, 
both of whom were HIV-antibody positive. The two IDUs injected first and the respondent recalled 
that he was hesitant to use the needle. One of the other IDUs showed him that they had placed 
plastic lining (from a carry/grocer bag) within the syringe and that this technique would protect the 
respondent from infectious disease, despite his use of the same needle. The respondent injected 
at that time and recalled that the other IDU had learned the ‘‘lining’’ technique while incarcerated 
in prison in the south of Ireland (080). 
 
The data suggest that some study participants were unaware that other injection equipment (e.g., 
spoons, containers, water, cotton) and practices (separating drugs for use by two or more people) 
can serve as conduits for the spread of infectious diseases. In fact, some researchers have 
suggested that these methods might be responsible for the high incidence of Hepatitis C among 
injecting drug users (37). A male respondent described his most recent injection experience. 
Heroin or other drugs were not available so he injected the MST residue from another injector’s 
filter:  
 
‘‘I know that person didn’t have AIDS’’ (053, age 29). 
 
Similarly, study participants noted the apparent lack of knowledge among other injectors: 
 
‘‘People [in NI] share spoons,etc. Hep C can live for some time on a spoon’’ (051, age 
48). 
 
‘‘They thought they’d use my water . . . they’re careless’’ (009, age 25). 
 
DISCUSSION 
The results from the present study show that several IDUs in Northern Ireland engage in various 
behaviors that pose risk for infectious diseases. In particular, ‘‘sharing’’ (i.e., loaning or borrowing) 
of needles and other injection equipment can involve blood-borne contact which places injection 
drug users at risk for exposure to HIV, and Hepatitis B and C (38). In the present study, many of 
these risk behaviors appear to be related to the limited supply and availability of needles/syringes. 
 
Drug policies can affect risk behaviors that contribute to the spread of infectious diseases such as 
HIV (39). HIV among IDUs in New York spread very quickly, and during that time sterile needles 
for use by IDUs were not widely available (40). The rapid spread of HIV in New York occurred 
also because IDUs were sharing with several other IDUs in friendship networks and within brief 
spans of time (38). In the late 1980s, laws that prohibited the possession of needles/syringes 
without prescription were not enforced in Glasgow, wherein the rate of HIV infection among 
injectors was 5%. Alternatively, the rate of HIV was 50 percent among injectors in Edinburgh 
(U.K.), where needle possession laws were rigorously enforced (41). In fact, HIV among injectors 
spread very quickly, i.e., within twoyea rs, in Edinburgh (42) largely because of the restricted 
availability of injecting equipment’’ (43). Escalating HIV incidence rates within brief time periods 
also have been reported in other countries (40). For example, HIV among IDUs in Manipur, North 
India was virtually non-existent in 1989 but within one year the rate among IDUs had escalated to 
54% (44). 
 
In comparison to other European regions, available data regarding the prevalence and incidence 
of HIV among IDUs in Northern Ireland suggest that these rates are low. However, studies that 
examine the rate of voluntary testing among IDUs in Northern Ireland are lacking. Although 
treatment and medical professionals can encourage IDUs to seek testing for HIV antibodies, the 
majority of participants in the present study had never been exposed to formal treatment for 
heroin use and several had never disclosed their drug histories to medical or health professionals. 
These findings suggest the possibility that several IDUs in Northern Ireland have not undergone 
testing for HIV, in which case the official data are likely to be underestimated. 
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Harm reduction policies have been shown to reduce the spread of HIV. Evidence suggests, for 
example, that in comparison to the United States, HIV failed to reach epidemic proportions in 
Australia largely because of the early implementation of several harm reduction policies, e.g., 
methadone, needle exchange, education for injectors (45). In particular, needle exchange 
programs have been found to affect the HIV seroprevalence rate. An international survey that 
included several cities (most located within the United States) found that seroprevalence declined 
by 5.8% per year in those cities that had offered needle exchange but had increased in those 
cities that did not offer needle exchange (46). 
 
To date Northern Ireland for the most part, has failed to implement basic harm reduction 
strategies. In fact, drug policy in the region differs substantially from elsewhere in the United 
Kingdom. The degree to which current drug policy in Northern Ireland will contribute to the spread 
of HIV and other infectious diseases is not known. Data from this study, however, suggest that 
risk behaviors among IDUs in Northern Ireland are commonplace. Additionally, a number of IDUs 
in the present study initiated use in other countries, and in places that have (reportedly) higher 
rates of HIV infection among injectors than in Northern Ireland. Several other respondents had 
injected in other countries, and at various points in the heroin career. Travel between countries 
among the IDU population and during the injection career, has been identified as a major factor in 
introducing the virus to the home country (40). The geographic proximity of Northern Ireland to 
other high injecting areas should not be ignored. For example, the United Nations International 
Drug Control Programme (47) has identified six ‘‘factors’’ that ‘‘appear to facilitate the emergence 
of injection as a pattern of drug abuse,’’ of which ‘‘geographical proximity to a country or region 
where injecting is commonplace’’ is included. The geographic proximity of Northern Ireland to 
regions characterized by large numbers of injectors (e.g., Dublin, Glasgow) when combined with 




Heroin users in Northern Ireland represent a marginalized and hidden population. The sampling 
strategy (largely snowball) and data collection procedure (in-depth interviews) were the most 
appropriate methods for studying members of this subculture. However, by relying on a non-
random sample of heroin users, the extent to which the views expressed by respondents reflect 
the experiences of the population of heroin users in Northern Ireland is unknown. Therefore, 
drawing inferences to the general population of heroin users in Northern Ireland is inappropriate. 
 
A second potential limitation focuses on one characteristic of the sample. Most studies of heroin 
users have relied on treatment sites and related agencies for recruitment of respondents. As a 
consequence, we have little information about heroin users who are not in contact with support 
services (48). In a sense, the present study filled this void to some extent in that the majority of 
respondents had never completed a treatment program and others had no exposure to treatment 
at all. Alternatively, the present study provides little information about persons who have 
completed drug user treatment in Northern Ireland and who have abstained from heroin for long 
periods of time. On several occasions the researcher sought to recruit heroin users from 
treatment sites but was not successful in this regard. 
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